CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Free Report) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 54,200 shares, an increase of 30.6% from the November 30th total of 41,500 shares. Currently, 0.9% of the shares of the company are short sold. Based […]
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 67,000 shares, a decline of 45.2% from the August 31st total of 122,300 shares. Currently, 1.6% of the company’s stock are sold short. […]